Table 1.
Profile of patients at their first visit during reporting period Q1 2018 – Q3 2019, Ulaanbaatar
| Diagnosed | Treated | Controlled BP (at the last visit) | Among all patients, with data | |||||
|---|---|---|---|---|---|---|---|---|
| Total N = 11,189 | % | Total N = 10,075 | % | Total N = 1986 | % | Treated Crude OR (95% CI) | BP Controlled Crude OR (95% CI) | |
| Age (years) | ||||||||
| 18–29 | 150 | 1·3 | 83 | 0 8 | 8 | 0·4 | REF | REF |
| 30–44 | 1050 | 9·4 | 800 | 7·9 | 107 | 5·4 | 2·6 (1·8, 3·7) ¥¥¥ | 2·0 (0·9, 4·9) |
| 45–59 | 3811 | 34·1 | 3385 | 33·6 | 579 | 29·2 | 6·4 (4·5, 9·1) ¥¥¥ | 3·2 (1·6, 7·5) ¥¥¥ |
| 60–69 | 3496 | 31·2 | 3279 | 32·5 | 639 | 32·3 | 12·2 (8·4, 17·5) ¥¥¥ | 4·0 (1·9, 9·4) ¥¥¥ |
| 70–79 | 1918 | 17·1 | 1800 | 17·9 | 463 | 23·4 | 12·3 (8·3, 18·1) ¥¥¥ | 5·6 (2·8, 13·4) ¥¥¥ |
| ≥ 80 | 729 | 6·5 | 693 | 6·9 | 190 | 9·6 | 15·5 (9·5, 25·5) ¥¥¥ | 6·2 (3·0, 15·0) ¥¥¥ |
| Missing age information | 35 | 0·3 | 35* | 0·3 | 0** | 0·0 | NA | NA |
| Sex | REF: MEN | REF: MEN | ||||||
| Women | 7029 | 62·8 | 6371 | 63·2 | 1344 | 67·8 | 1·2 (1·0, 1·4) ¥¥ | 1·3 (1·2, 1·5) ¥¥¥ |
| Missing sex information | 13 | 0·1 | 12 | 0·1 | 3 | 0·2 | NA | NA |
| BP Categories (mmHg) | ||||||||
| < 120 and < 80 mmHg | 362 | 3·2 | 335 | 3·3 | 90 | 4·5 | REF | REF |
| 120–129 or 80–84 mmHg | 704 | 6·3 | 672 | 6·7 | 170 | 8·6 | 1·7 (1·0, 3·0) ¥ | 1·0 (0·7, 1·3) |
| 130–139 or 85–89 mmHg | 2252 | 20·1 | 1871 | 18·6 | 331 | 16·7 | 0·4 (0·3, 0·6) ¥¥¥ | 0·5 (0·4, 0·7) ¥¥¥ |
| 140–159 or 90–99 mmHg | 3632 | 32·5 | 3184 | 31·6 | 433 | 21·9 | 0·6 (0·4, 0·9) ¥¥ | 0·4 (0·3, 0·5) ¥¥¥ |
| 160–179 or 100–109 mmHg | 2185 | 19·5 | 2014 | 20·0 | 328 | 16·6 | 0·9 (0·6, 1·5) | 0·5 (0·4, 0·7) ¥¥¥ |
| ≥ 180 or ≥ 110 mmHg | 726 | 6·5 | 680 | 6·7 | 109 | 5·5 | 1·2 (0·7, 2·0) | 0·5 (0·4, 0·7) ¥¥¥ |
| Missing BP information | 1328 | 11·9 | 1319*** | 13·1 | 525*** | 26·5 | NA | NA |
| CV Riska | ||||||||
| Low | 3636 | 32·5 | 3511 | 34·8 | 690 | 34·8 | REF | REF |
| Moderate/Intermediate | 2874 | 25·7 | 2816 | 28·0 | 406 | 20·5 | 1·7 (1·3, 2·4) ¥¥¥ | 0·7 (0·6, 0·8) ¥¥¥ |
| High | 565 | 5·0 | 547 | 5·4 | 99 | 5·0 | 1·1 (0·7, 1·9) | 0·9 (0·7, 1·1) |
| Missing | 4144 | 37·0 | 3201*** | 31·8 | 791** | 39·9 | NA | NA |
Chi-square test or statistical significance for missingness of patient characteristic data *p < 0·05, **p < 0·01, ***p < 0·001
BP blood pressure, CI confidence intervals, CV cardiovascular, NA not applicable, OR odds ratio, REF reference
aCV risk was defined according to city-specific guidelines (see S3 Table)
Crude odds ratios and 95% CIs estimated only among patients with non-missing data and rounded to one decimal place; ¥p < 0·05, ¥¥p < 0·01, ¥¥¥p < 0·001